Details for New Drug Application (NDA): 206769
✉ Email this page to a colleague
NDA 206769 describes ARGATROBAN IN 0.9% SODIUM CHLORIDE, which is a drug marketed by Teva Pharms Usa and is included in one NDA. Additional details are available on the ARGATROBAN IN 0.9% SODIUM CHLORIDE profile page.
The generic ingredient in ARGATROBAN IN 0.9% SODIUM CHLORIDE is argatroban. There are eleven drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the argatroban profile page.
The generic ingredient in ARGATROBAN IN 0.9% SODIUM CHLORIDE is argatroban. There are eleven drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the argatroban profile page.
Summary for 206769
| Tradename: | ARGATROBAN IN 0.9% SODIUM CHLORIDE |
| Applicant: | Teva Pharms Usa |
| Ingredient: | argatroban |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INTRAVENOUS | Strength | 250MG/250ML (1MG/ML) | ||||
| Approval Date: | Dec 15, 2014 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
